Vivos Therapeutics (VVOS) Net Cash Flow (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Net Cash Flow of $91000.0 for Q1 2026, up 102.32% year-over-year from $44978.2 in Q1 2025, and up 109.02% quarter-over-quarter from -$1.0 million in Q4 2025.
Vivos Therapeutics (VVOS) Net Cash Flow (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Net Cash Flow for 7 consecutive years, with $91000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 102.32% year-over-year to $91000.0; the TTM figure through Mar 2026 stood at -$11.7 million (down 4041.13% YoY), while the FY2025 annual figure was -$4.2 million, down 191.82% from the prior year.
- Net Cash Flow improved to $91000.0 in Q1 2026 per VVOS's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $4.3 million in Q2 2024 and bottomed at -$9.4 million in Q2 2025.
- Historically, Net Cash Flow has averaged -$2.0 million across 5 years, with a median of -$1.4 million in 2025.
- Annual changes were most pronounced in 2024 — Net Cash Flow soared 237.11% — and 2025, when it tumbled 1581.67%.
- Vivos Therapeutics' Net Cash Flow stood at -$3.2 million in 2022, then surged by 121.82% to $701000.0 in 2023, then tumbled by 108.56% to -$60000.0 in 2024, then sank by 1581.67% to -$1.0 million in 2025, then jumped by 109.02% to $91000.0 in 2026.
- Business Quant data shows VVOS's Net Cash Flow at $91000.0 in Q1 2026, -$1.0 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | -378,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -60,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | -556,000.00 |
| Sep 30, 2024 | -556,000.00 |
| Jun 30, 2024 | 4.26 Mn |
| Jun 30, 2024 | 4.26 Mn |
| Mar 31, 2024 | 968,000.00 |
| Mar 31, 2024 | 968,000.00 |
| Dec 31, 2023 | 701,000.00 |
| Dec 31, 2023 | 701,000.00 |